No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AQST Aquestive Therapeutics
- 4.070
- +0.140+3.56%
Close Apr 26 16:00 ET
- 3.970
- -0.100-2.46%
Post 19:59 ET
366.17MMarket Cap-31307P/E (TTM)
4.250High3.950Low2.99MVolume4.000Open3.930Pre Close12.36MTurnover3.74%Turnover RatioLossP/E (Static)89.97MShares6.23052wk High-3.44P/B324.79MFloat Cap1.25152wk Low--Dividend TTM79.80MShs Float20.696Historical High--Div YieldTTM7.63%Amplitude0.618Historical Low4.139Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | FDA Approves Aquestive Therapeutics' Libervant- Website
Express News | Aquestive Therapeutics Dips Amid Volume Spike, Last Down 6.0%
OPI, RVNC and AQST Are Among After Hour Movers
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday.Shares of Ally Financial Inc. (NYSE:ALLY) rose sharply during Thursday's session after the company reported better-
Express News | Aquestive Therapeutics To Present Crossover Study Data For Libervant Buccal Film At 76th Annual Meeting Of American Academy Of Neurology
Aquestive Therapeutics to Present Crossover Study Data for Libervant (Diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced a poster presentation highlighting the crossover study for the Company's product candidate, Libervant (diazepam) Buccal Film for treatment of children with epilepsy aged two to five, will be presented at the 76th Annual Meeting of the American Academy of Neurology (AAN) in Denver from April 13 to 18, offering both in-person attendance and live online participation in a hybrid format.
Comments
$Aquestive Therapeutics(AQST.US$
From AQST website
“LibervantTM
A meaningful contribution to improved patient care
The FDA has granted tentative approval of LibervantTM(diazepam buccal film). Aquestive is prepared to commercially launch Libervant, if approved for U.S. market access. Libervant is a Diazepam Buccal Film developed as an oral rescue therapy for patients with breakthrough seizures or seizure clusters.”
From AQST website
“LibervantTM
A meaningful contribution to improved patient care
The FDA has granted tentative approval of LibervantTM(diazepam buccal film). Aquestive is prepared to commercially launch Libervant, if approved for U.S. market access. Libervant is a Diazepam Buccal Film developed as an oral rescue therapy for patients with breakthrough seizures or seizure clusters.”
2
2
$Aquestive Therapeutics(AQST.US$
EARNINGS PREVIEW
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Aquestive Therapeutics Inc AQST.OQ AQST.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG da...
EARNINGS PREVIEW
Aquestive Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Aquestive Therapeutics Inc AQST.OQ AQST.O is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2024
The Warren New Jersey-based company is expected to report a 10.1% increase in revenue to $12.262 million from $11.13 million a year ago, according to the mean estimate from 8 analysts, based on LSEG da...
4
$Aquestive Therapeutics(AQST.US$ Bigger dip so I can buy more
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
HH1000 : approved yet post market closes red. i think shorties are gonna keep it down
Jaguar8OP HH1000: Yes you have to check on DP and shorts availability. Also, people who bought this days or weeks ago, closed their position when it got approved. You can see this in the order book.
Not all FDA approval soars. It really depends on a lot of factors.